文献速递认知障碍与谵妄多重用药老年慢病共病管理

长期护理机构中阿尔茨海默病及痴呆的药物治疗:真实世界电子健康记录研究

Pharmacotherapy for Alzheimer's Disease and Dementias in Long-Term Care: A Real-World EHR Study.
PubMed 文献 · J Am Med Dir Assoc · 2026-07-03

该回顾性观察研究基于美国长期护理机构1675873名居民中295946名有ADRD诊断者的电子健康记录,分析ADRD药物医嘱模式。结果显示82.0%有至少1条ADRD药物医嘱,治疗率因痴呆亚型、种族和住院时长等因素差异显著,约五分之一患者未接受ADRD药物治疗。

要点

  • 82.0%的ADRD居民有至少1条ADRD药物医嘱,约五分之一未治疗。
  • 路易体痴呆(91.1%)和早发型AD(90.3%)治疗率最高,亚裔(72.3%)和短期住院者(75.6%)最低。
  • 接受治疗者平均用药负担更高(8.6 vs 6.3),糖尿病与治疗几率降低相关。

核心结论

  • 约五分之一的ADRD长期护理居民没有ADRD药物医嘱,且治疗率因非临床因素显著变化。

研究设计与样本

  • 回顾性观察研究,使用PointClickCare Life Sciences临床数据库,纳入美国 skilled nursing facilities 中1675873名长期护理居民,其中295946名有ADRD诊断且研究窗口结束时仍在机构。

主要发现

  • 总体82.0%的ADRD居民有至少1条ADRD药物医嘱。
  • 治疗率最高为路易体痴呆(91.1%)和早发型AD(90.3%),最低为亚裔(72.3%)、夏威夷原住民或其他太平洋岛民(74.6%)和短期住院居民(75.6%)。
  • 接受治疗者平均用药负担为8.6,未治疗者为6.3。
  • 糖尿病与治疗几率降低相关,而ADRD亚型强烈预测治疗。

临床怎么用

  • 应关注ADRD药物治疗中的潜在差异,尤其针对亚裔、太平洋岛民和短期住院居民。
  • 对ADRD患者需优化多重用药管理,并关注糖尿病等共病对治疗决策的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To characterize contemporary pharmacologic medication order patterns for Alzheimer's disease (AD) and related dementias (ADRD) among US long-term care (LTC) residents and to examine facility- and resident-level factors associated with treatment. DESIGN: Retrospective and observational study. SETTING AND PARTICIPANTS: Electronic health record data from 1,675,873 LTC residents in the PointClickCare Life Sciences clinical database included 295,946 with a documented ADRD diagnosis in skilled nursing facilities in the United States who remained in facility at the end of the study window (January-April 2025). METHODS: Residents were classified as treated/untreated based on the presence of ≥1 ADRD medication order as outlined by the Alzheimer's Association. Analyses incorporated demographics, comorbidities, medication burden, and facility characteristics. Multivariate logistic regression estimated the odds of having an ADRD medication order. RESULTS: Overall, 82.0% of residents with ADRD had ≥1 order for ADRD medication. Treatment was most common among residents with Lewy body dementia (91.1%) and early onset AD (90.3%) and least frequent among Asian (72.3%), Native Hawaiian, or Other Pacific Islander (74.6%) and short-stay residents (75.6%). Treated residents exhibited a higher medication burden (mean, 8.6 vs 6.3). Diagnoses for other chronic conditions as well as specific ADRD subtypes strongly impacted probability of treatment; diabetes was associated with lower odds of treatment, whereas ADRD subtypes strongly predicted treatment. CONCLUSIONS AND IMPLICATIONS: Approximately one-fifth of residents with ADRD did not have an ADRD medication order, and treatment varied significantly by nonclinical predictors. These findings underscore the need to investigate and understand possible treatment disparities, optimize polypharmacy management, and discover new ADRD treatments, and develop safer and more effective ADRD therapies.

来源:J Am Med Dir Assoc,查看原文。版权归原作者所有。

引用

  1. Saumur TM, Ashraf H, Mathers KE, et al. Pharmacotherapy for Alzheimer's Disease and Dementias in Long-Term Care: A Real-World EHR Study. J Am Med Dir Assoc. 2026. PMID: 42398193. doi:10.1016/j.jamda.2026.106293

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。